NASDAQ Composite ended the session with Catalyst Pharmaceuticals jumping 3.06% to $3.71 on Monday, after two consecutive sessions in a row of losses. NASDAQ Composite rose 0.26% to $13,577.94, after four successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Catalyst Pharmaceuticals today’s close was $3.71, 42.32% below its 52-week high of $5.28.

Catalyst Pharmaceuticals’s Sales

Catalyst Pharmaceuticals’s sales growth is 0.8% for the present quarter and 5.5% for the next. The company’s growth estimates for the current quarter is 12.5% and a drop 20% for the next.

Catalyst Pharmaceuticals’s Revenue

Year-on-year quarterly revenue growth declined by 5.1%, now sitting on 118.18M for the twelve trailing months.


Catalyst Pharmaceuticals’s last day, last week, and last month’s average volatility was a negative 1.94%, a positive 0.40%, and a positive 0.13%, respectively.

Catalyst Pharmaceuticals’s last day, last week, and last month’s high and low average amplitude percentage was 3.69%, 4.25%, and 4.14%, respectively.

Catalyst Pharmaceuticals’s Stock Yearly Top and Bottom Value

Catalyst Pharmaceuticals’s stock is valued at $3.71 at 16:09 EST, way below its 52-week high of $5.28 and way above its 52-week low of $2.55.

Catalyst Pharmaceuticals’s Moving Average

Catalyst Pharmaceuticals’s worth is higher than its 50-day moving average of $3.54 and higher than its 200-day moving average of $3.58.


Please enter your comment!
Please enter your name here